Core Viewpoint - The establishment of the Sci-Tech Innovation Board's growth tier allows unprofitable tech companies to access capital markets, marking a significant shift in the valuation system for hard tech firms [1][2]. Group 1: Introduction of Unprofitable Companies - Three unprofitable new stocks—He Yuan Bio, Xi'an Yicai, and Bibet—are set to launch online subscriptions, becoming the first batch of new registered companies in the growth tier of the Sci-Tech Innovation Board [1]. - This marks the return of unprofitable companies to the Sci-Tech Innovation Board after more than two years, following the China Securities Regulatory Commission's announcement in June to establish a growth tier focused on tech firms with significant breakthroughs and commercial potential [1]. Group 2: Valuation System Restructuring - The growth tier provides a new valuation dimension for hard tech companies, replacing short-term profit indicators with metrics like "degree of technological breakthrough" and "commercialization prospects," allowing for the quantification and recognition of technological value in capital markets [1]. - The introduction of professional institutional investors aims to enhance market evaluation of the technological attributes and commercial prospects of these tech firms [1]. Group 3: Resource Allocation Efficiency - Institutional innovations not only reconstruct valuation logic but also enhance resource allocation efficiency, addressing challenges faced by hard tech companies during critical R&D phases and in industry consolidation [2]. - Measures such as allowing unprofitable companies to raise funds from existing shareholders and supporting mergers of listed companies aim to alleviate funding shortages and obstacles in resource integration [2]. Group 4: Risk Management - The growth tier includes a "U" label for risk warning and strengthens investor suitability management, striving to balance support for innovation with risk prevention [2].

Core Viewpoint - The establishment of the Sci-Tech Innovation Board's growth tier marks a significant opportunity for unprofitable tech companies to access capital markets, indicating a shift in the valuation framework for these firms [1][2]. Group 1: Introduction of the Growth Tier - Three unprofitable new stocks—He Yuan Bio, Xi'an Yicai, and Bibet—are set to launch online subscriptions, becoming the first new registered companies in the growth tier of the Sci-Tech Innovation Board [1]. - This is the first time in over two years that unprofitable companies will be welcomed on the Sci-Tech Innovation Board, following the China Securities Regulatory Commission's announcement in June to establish the growth tier [1]. Group 2: Valuation System Restructuring - The growth tier not only opens doors for unprofitable hard tech companies but also reshapes the valuation system for these firms, which have historically struggled to achieve reasonable pricing under traditional profit-oriented valuation frameworks [2]. - The new valuation approach emphasizes "technological breakthroughs" and "commercialization prospects" over short-term profit metrics, allowing for a quantifiable recognition of technological value in the capital market [2]. Group 3: Institutional Support and Resource Allocation - The introduction of seasoned institutional investors aims to enhance market evaluation of tech companies' innovation attributes and commercial potential [2]. - Innovative measures, such as allowing unprofitable companies to raise funds from existing shareholders and supporting mergers of companies listed on the Sci-Tech Innovation Board for less than three years, address funding challenges during critical R&D phases [2]. Group 4: Risk Management and Investor Protection - The growth tier includes a "U" label for risk indication and strengthens investor suitability management, striving to balance innovation support with risk prevention [2].